Examples Interpretation of WHO Guidelines_Chinese Journal of Evidence-Based Medicine

Authors：

 DINGHong-fan ¹ ^# ,  XIAOShu-jun ² ^# , YANGNan ³ , DENGWei ¹ , LILe ³ , WANGQi ^4,5,6 , WANGXiao-qin ^4,5,6 , WUQiong-fang ⁷ , WEIDang ^4,5,6 , YAOLiang ^4,5,6 ,  CHENYao-long ^4,5,6 , YANGKe-hu ^4,5,6

1. 北京大学第一医院麻醉科（北京 100034）;
2. The Second Hospital of Lanzhou University, Lanzhou 730000, China;
3. School of Basic Medical Sciences, Lanzhou University, Lanzhou 730000, China;
4. The First Hospital of Lanzhou University, Lanzhou 730000, China;
5. Evidence-Based Medicine Center, Lanzhou University, Lanzhou 730000, China;
6. Key Laboratory of Evidence-Based Medicine and Knowledge Translation of Gansu Province, Lanzhou 730000, China;
7. Chinese GRADE Center, Lanzhou University, Lanzhou 730000, China. 7. Department of Anesthesiology, Peking University First Hospital, Beijing 100034, China;

Corresponding author：

CHENYao-long, Email: chenyaolong21@163.com

Keywords：

WHO guidelines; Guideline interpretation; Public health

DOI：

10.7507/1672-2531.20160074

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

In order to help Chinese guideline developers, clinicians, health policy makers and other relevant researchers fully understand and make appropriate use of World Health Organization (WHO) guidelines, Chinese GRADE Center and Guidelines Review Committee of World Health Organization (WHO-GRC) have written a series of papers about development methods, review principles and the structure and content of WHO guidelines. This is the third (also last) paper which interpreted Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection and Guidelines for the Screening, Care and Treatment of Persons with Hepatitis C Infection as examples with the process and steps of WHO guideline development.

Citation： DINGHong-fan, XIAOShu-jun, YANGNan, DENGWei, LILe, WANGQi, WANGXiao-qin, WUQiong-fang, WEIDang, YAOLiang, CHENYao-long, YANGKe-hu. Examples Interpretation of WHO Guidelines. Chinese Journal of Evidence-Based Medicine, 2016, 16(4): 482-487. doi: 10.7507/1672-2531.20160074 Copy

1.	丁泓帆, 杨楠, 邓围, 等. WHO指南制定的基本原则和方法. 中国循证医学杂志, 2016, 16(4):471-477.
2.	丁泓帆, 邓围, 杨楠, 等. WHO指南评审原则与方法. 中国循证医学杂志, 2016, 16(4):478-481.
3.	World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Geneva:World Health Organization, 2013.
4.	World Health Organization. Guidelines for the screening, care and treatment of persons with hepatitis C infection. Geneva:World Health Organization, 2014.
5.	World Health Organization. WHO Handbook for guideline development. Geneva:World Health Organization, 2008.
6.	World Health Organization. WHO Handbook for guideline development. Geneva:World Health Organization, 2010.
7.	World Health Organization. WHO handbook for guideline development. Geneva:World Health Organization, 2012.
8.	World Health Organization. WHO Handbook of Guideline Development 2nd edition. Geneva:World Health Organization, 2014.
9.	Guyatt G, Oxman AD, Akl EA, et al. GRADE guidelines:1. Introduction-GRADE evidence profiles and summary of fi ndings tables. J Clin Epidemiol, 2011, 64(4):383-394.
10.	Guyatt G, Oxman AD, Akl E, 等. GRADE 指南:Ⅰ. 导论——GRADE证据概要表和结果总结表. 中国循证医学杂志, 2011, 11(4):437-445.
11.	Andrews JC, Schünemann HJ, Oxman AD, et al. GRADE guidelines:15. Going from evidence to recommendation-determinants of a recommendation's direction and strength. J Clin Epidemiol, 2013, 66(7):726-735.
12.	Brouwers MC, Kho ME, Browman GP, et al. AGREE Ⅱ:advancing guideline development, reporting and evaluation in health care. CMAJ, 2010, 182(18):421-424.

1. 丁泓帆, 杨楠, 邓围, 等. WHO指南制定的基本原则和方法. 中国循证医学杂志, 2016, 16(4):471-477.
2. 丁泓帆, 邓围, 杨楠, 等. WHO指南评审原则与方法. 中国循证医学杂志, 2016, 16(4):478-481.
3. World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Geneva:World Health Organization, 2013.
4. World Health Organization. Guidelines for the screening, care and treatment of persons with hepatitis C infection. Geneva:World Health Organization, 2014.
5. World Health Organization. WHO Handbook for guideline development. Geneva:World Health Organization, 2008.
6. World Health Organization. WHO Handbook for guideline development. Geneva:World Health Organization, 2010.
7. World Health Organization. WHO handbook for guideline development. Geneva:World Health Organization, 2012.
8. World Health Organization. WHO Handbook of Guideline Development 2nd edition. Geneva:World Health Organization, 2014.
9. Guyatt G, Oxman AD, Akl EA, et al. GRADE guidelines:1. Introduction-GRADE evidence profiles and summary of fi ndings tables. J Clin Epidemiol, 2011, 64(4):383-394.
10. Guyatt G, Oxman AD, Akl E, 等. GRADE 指南:Ⅰ. 导论——GRADE证据概要表和结果总结表. 中国循证医学杂志, 2011, 11(4):437-445.
11. Andrews JC, Schünemann HJ, Oxman AD, et al. GRADE guidelines:15. Going from evidence to recommendation-determinants of a recommendation's direction and strength. J Clin Epidemiol, 2013, 66(7):726-735.
12. Brouwers MC, Kho ME, Browman GP, et al. AGREE Ⅱ:advancing guideline development, reporting and evaluation in health care. CMAJ, 2010, 182(18):421-424.

Previous Article
Review Principles and Methods of WHO Guidelines
Next Article
How to Conduct Dose-response Meta-analysis:Method of Adjustment of Non-randomized Error

Chinese Journal of Evidence-Based Medicine

Examples Interpretation of WHO Guidelines

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content